Linda West insider trades

Open-market stock purchases and sales by Linda West, Director at Context Therapeutics Inc, from SEC Form 4 filings since Mar 31, 2020.

Track record: 0% of 5 scored buys are up 5% or more since purchase, averaging -98%.

Recent trades

DateStockTradeValue
Jun 24, 2026CNTX Context Therapeutics IncBought (not open market)—

Companies traded

  • CNTX Context Therapeutics Inc: other filings, last Jun 24, 2026
  • GRTX Galera Therapeutics, Inc: 5 buys, last Jul 1, 2023

Get free alerts when Linda West files a new trade →